Bioqual (OTCMKTS:BIOQ) & OneMedNet (NASDAQ:ONMD) Critical Comparison

Bioqual (OTCMKTS:BIOQGet Free Report) and OneMedNet (NASDAQ:ONMDGet Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

Valuation and Earnings

This table compares Bioqual and OneMedNet’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bioqual $62.66 million N/A $840,000.00 ($0.51) -147.06
OneMedNet $1.02 million 14.47 -$23.20 million ($0.19) -3.26

Bioqual has higher revenue and earnings than OneMedNet. Bioqual is trading at a lower price-to-earnings ratio than OneMedNet, indicating that it is currently the more affordable of the two stocks.


This table compares Bioqual and OneMedNet’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bioqual -0.76% -1.22% -0.77%
OneMedNet N/A N/A -116.74%

Insider and Institutional Ownership

0.9% of OneMedNet shares are held by institutional investors. 39.2% of Bioqual shares are held by insiders. Comparatively, 45.7% of OneMedNet shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Bioqual and OneMedNet, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bioqual 0 0 0 0 N/A
OneMedNet 0 0 0 0 N/A

Volatility & Risk

Bioqual has a beta of -0.32, indicating that its stock price is 132% less volatile than the S&P 500. Comparatively, OneMedNet has a beta of -0.55, indicating that its stock price is 155% less volatile than the S&P 500.


OneMedNet beats Bioqual on 6 of the 10 factors compared between the two stocks.

About Bioqual

(Get Free Report)

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

About OneMedNet

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. The company is based in Eden Prairie, Minnesota.

Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with's FREE daily email newsletter.